Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-05-13 @ 11:47 PM
Study NCT ID:
NCT06750094
Status:
RECRUITING
Last Update Posted:
2025-12-19
First Post:
2024-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Sponsor:
Organization: